
Motus GI Investor Relations Material
Latest events

Q3 2022
Motus GI

Q1 2024
14 May, 2024

Q4 2023
18 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Motus GI Holdings Inc
Access all reports
Motus GI Holdings, Inc. is a medical technology company specializing in the development of solutions to enhance the effectiveness of colonoscopy procedures. The company’s flagship product is a system designed to improve visualization during colonoscopies by facilitating the removal of bowel contents, which helps in detecting abnormalities and reduces the need for repeat procedures. Motus GI primarily serves healthcare providers and aims to improve patient outcomes and procedural efficiency in gastrointestinal care. The company is headquartered in Fort Lauderdale, United States, and its shares are listed on the NASDAQ.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
MOTS
Country
🇺🇸 United States